基本信息
views: 267
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Cairncross is best known for contributions to neuro-oncology. He discovered that oligodendroglioma, a type of brain cancer, is sensitive to chemotherapy, and he and David Louis co-discovered a molecular marker of their drug sensitivity. Testing for this marker is now used worldwide to guide the treatment of patients with oligodendroglioma. A trial led by Dr. Cairncross showed that patients with this genetic subtype of oligodendroglioma live twice as long when chemotherapy is a part of their treatment. His contributions to the understanding and treatment of brain cancer have been cited nearly 50,000 times.
Research Interests
Papers共 412 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International Journal of Radiation Oncology*Biology*Physics (2024)
crossref(2023)
Cancersno. 10 (2023): 2805
crossref(2023)
bioRxiv (2022)
Load More
Author Statistics
#Papers: 415
#Citation: 63320
H-Index: 87
G-Index: 251
Sociability: 8
Diversity: 3
Activity: 29
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn